Heidelberg Pharma AG
DUS:HPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Heidelberg Pharma AG
DUS:HPHA
|
DE |
|
M
|
Marchex Inc
XMUN:NHM
|
US |
|
D
|
Dow Inc
F:2OY
|
US |
|
Vericel Corp
NASDAQ:VCEL
|
US |
|
Modine Manufacturing Co
NYSE:MOD
|
US |
|
I
|
I&I Group PCL
SET:IIG
|
TH |
Wall St Price Targets
HPHA Price Targets Summary
Heidelberg Pharma AG
According to Wall Street analysts, the average 1-year price target for HPHA is 5.29 EUR with a low forecast of 5.24 EUR and a high forecast of 5.45 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HPHA's stock price target?
Price Target
5.29
EUR
According to Wall Street analysts, the average 1-year price target for HPHA is 5.29 EUR with a low forecast of 5.24 EUR and a high forecast of 5.45 EUR.
What is the Revenue forecast for Heidelberg Pharma AG?
Projected CAGR
202%
Over the last 9 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 2 years is 202%.
What is the Gross Profit forecast for Heidelberg Pharma AG?
Projected CAGR
26%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 5 years is 26%.
